← Open Payments lookup

TAI PHUNG: Open Payments

NPI 1760098032 · ROSEMEAD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,454 in 74 payments from 12 companies in 2025. Trend: 2023 $1,082 · 2024 $1,586 · 2025 $3,454

Food & beverage: $3,454
CompanyPaymentsAmount
Alkermes, Inc.16$588
Janssen Pharmaceuticals, Inc7$581
Vanda Pharmaceuticals Inc.12$553
Teva Pharmaceuticals USA, Inc.4$357
E.R. Squibb & Sons, L.L.C.5$336
Otsuka America Pharmaceutical, Inc.12$312
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$282
Neurocrine BioSciences, Inc.9$172
Axsome Therapeutics, Inc.1$123
Janssen Biotech, Inc.1$123

Products named: INVEGA SUSTENNA, ARISTADA, COBENFY, REXULTI, HETLIOZ, CAPLYTA, AUSTEDO XR, FANAPT.

Industry payments across CA — which companies pay providers there.